Maria J de Miguel M.D., PhD

Maria J de Miguel, M.D., Ph.D., is a Medical Oncologist and Principal Investigator of START Madrid-CIOCC. She is also a Clinical Associated Professor of Medicine at the CEU University San Pablo, Madrid, Spain.

Maria J de Miguel finished her medical training in 2007 at the Malaga University. In 2012 she completed her Medical Oncology Specialization at the Virgen del Rocío University Hospital (HUVR) with the highest qualifications. During that time, she perfomed a Biomedical Research Master in the Biomedicine and Research Institute (IBIS Seville) and an internship in the Drug Development Unit of the Nederlands Kanker Instituut in Amsterdam, where she started being interested in Phase I clinical trials. After a couple of years working as a consultant in the Thoracic and Research Unit in the HUVR she decided to move to London in May 2014 to complete a fellowship in the Drug Development Unit of the Royal Marsden Hospital, directed by Prof. Johann de Bono. In 2015, she joined the ECCO-AACR-EORTC-ESMO workshop on methods in clinical cancer research (Flims), Switzerland. Also, in the same year she won the Bradley Stuart Merit Award for the highest-ranking abstract overall in the ASCO meeting. Back in Spain, she worked in the Gastrointestinal tumor unit of the National Research Cancer Center (CNIO) and afterwards was awarded her Phd in molecular laryngeal cancer biomarkers with Cum Laudedegree.

As of January 2017, she has been working at START Madrid-CIOCC as a Clinical Investigator at the Early Drug Development Unit. She has been involved in more than 100 Phase I clinical trials, including First in Human trial, immunotherapy trials, combinations of targeted therapies and immunotherapies, biomarker-driven trials, and trials in molecularly selected populations with special emphasis on gastrointestinal, head and neck, and thoracic tumors.

She is currently the Principal Investigator/Co-Investigator of over 60 early phase clinical trials of novel anticancer agents for patients with advanced solid tumors. She is authored and co-authored of several papers in peer-reviewed journals such as Annals of Oncology. Dr. de Miguel is a member of the American Society of Clinical Oncology and of the European Society of Medical Oncology.